123 related articles for article (PubMed ID: 8901915)
1. Pharmacokinetic model describing the disposition of butadiene and styrene in mice.
Leavens TL; Bond JA
Toxicology; 1996 Oct; 113(1-3):310-3. PubMed ID: 8901915
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure.
Filser JG; Johanson G; Kessler W; Kreuzer PE; Stei P; Baur C; Csanády GA
IARC Sci Publ; 1993; (127):65-78. PubMed ID: 8070888
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats.
Laib RJ; Tucholski M; Filser JG; Csanády GA
Arch Toxicol; 1992; 66(5):310-4. PubMed ID: 1610292
[TBL] [Abstract][Full Text] [Related]
4. Metabolic interactions of 1,3-butadiene and styrene in male B6C3F1 mice.
Leavens TL; Moss OR; Turner MJ; Janszen DB; Bond JA
Toxicol Appl Pharmacol; 1996 Dec; 141(2):628-36. PubMed ID: 8975788
[TBL] [Abstract][Full Text] [Related]
5. PBPK model for butadiene metabolism to epoxides: quantitative species differences in metabolism.
Johanson G; Filser JG
Toxicology; 1996 Oct; 113(1-3):40-7. PubMed ID: 8901881
[TBL] [Abstract][Full Text] [Related]
6. A preliminary regional PBPK model of lung metabolism for improving species dependent descriptions of 1,3-butadiene and its metabolites.
Campbell J; Van Landingham C; Crowell S; Gentry R; Kaden D; Fiebelkorn S; Loccisano A; Clewell H
Chem Biol Interact; 2015 Aug; 238():102-10. PubMed ID: 26079054
[TBL] [Abstract][Full Text] [Related]
7. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene.
Leavens TL; Farris GM; James RA; Shah R; Wong VA; Marshall MW; Bond JA
Environ Mol Mutagen; 1997; 29(4):335-45. PubMed ID: 9212784
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats.
Sweeney LM; Schlosser PM; Medinsky MA; Bond JA
Carcinogenesis; 1997 Apr; 18(4):611-25. PubMed ID: 9111190
[TBL] [Abstract][Full Text] [Related]
10. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man.
Csanády GA; Mendrala AL; Nolan RJ; Filser JG
Arch Toxicol; 1994; 68(3):143-57. PubMed ID: 8024461
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 2E1 decreases, but does not eliminate, genotoxicity mediated by 1,3-butadiene.
Jackson TE; Lilly PD; Recio L; Schlosser PM; Medinsky MA
Toxicol Sci; 2000 Jun; 55(2):266-73. PubMed ID: 10828257
[TBL] [Abstract][Full Text] [Related]
12. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
13. Health risk assessment of chemical mixtures from a research perspective.
Bond JA; Medinsky MA
Toxicol Lett; 1995 Dec; 82-83():521-5. PubMed ID: 8597104
[TBL] [Abstract][Full Text] [Related]
14. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene.
Bolt HM
IARC Sci Publ; 1993; (127):37-44. PubMed ID: 8070883
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadiene.
Sweeney LM; Himmelstein MW; Schlosser PM; Medinsky MA
Toxicology; 1996 Oct; 113(1-3):318-21. PubMed ID: 8901917
[TBL] [Abstract][Full Text] [Related]
16. 1,3-Butadiene: linking metabolism, dosimetry, and mutation induction.
Bond JA; Csanady GA; Gargas ML; Guengerich FP; Leavens T; Medinsky MA; Recio L
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):87-94. PubMed ID: 7698092
[TBL] [Abstract][Full Text] [Related]
17. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
19. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
